GeneWake GmbH is a pharmacogenomics company with a sound scientific background in biomarker analysis in the field of oncology. Our mission is to realize a personalized and tailor-made cancer treatment by targeted analysis of relevant gene expression levels in tumour tissue and in circulating tumour cells in blood. By employing bioinformatical algorithms based on our knowledge in pathway structure and microarray data from public sources, biomarker screening can be limited to a low-density scale. The output of 10-20 potential genes can be used for ptient stratification or therapy tracking.
In addition, GeneWake offers contract research like DNA and RNA sequencing and annotation, SNP genotyping, mutation detection, multiplex PCR, kit development, immune histology and genotyping for clinical studies.
GeneWake has not received any reviews.
GeneWake has not received any endorsements.